Fact check - The narrative mixes a number of scientific terms related to vaccines and then draws a false conclusion.
The company said it expects Qdenga to become available in India in the first half of 2027. Read more at straitstimes.com.
India approves QDENGA, its first dengue vaccine, offering protection against all four dengue virus strains for people aged 4 ...
Cecilia Ramirez spends her summer crisscrossing the Oklahoma City area. She drives a van decorated with smiling cartoon kids ...
India has approved its first dengue vaccine, QDENGA, for people aged 4 to 60 years. Know who can receive it, how the two-dose ...
India has approved its first dengue vaccine after DCGI granted market authorisation to Takeda's QDENGA. The vaccine is approved for people aged 4-60 years.
On July 16, the launch ceremony of the event themed A Century of Legacy, A Future of Shared Prosperity – Commemorative ...
Takeda Biopharmaceuticals India has received market authorization for its dengue vaccine QDENGA. This vaccine is now approved for individuals aged four to sixty years old. QDENGA offers protection ...
How effective is QDENGA? India approves its first dengue vaccine by Japanese drugmaker for ages 4-60
Takeda's QDENGA vaccine has been approval in India, becoming the first dengue vaccine authorised for use in the country ...
The vaccine was approved for individuals aged between 4 and 60 years. It can be administered irrespective of whether a person ...
A roadmap for returning the UK to spending 0.7 per cent of Gross National Income on international aid is to form part of a ...
India has approved its first dengue vaccine, QDENGA, for individuals aged 4 to 60 years. The DCGI clearance allows ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results